Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Radiothérapie de Blois

Verified siteinfo

France rue de l'octroi, 41260 La Chaussée Saint Victor, France

  • Squamous cell carcinoma of head and neck
  • Adult patients

About Specializations

Centre Radiothérapie de Blois in La Chaussée Saint Victor, France specialises in clinical trials of conditions such as Squamous cell carcinoma of head and neck, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, particularly in the treatment of head and neck cancers. The institution is pioneering studies that explore the combination of durvalumab with radiotherapy to enhance treatment efficacy and safety.

  • Head and Neck Cancer Treatment
  • Immunotherapy and Radiotherapy Synergy
  • Squamous Cell Carcinoma Management

By focusing on regional control of the disease, the center aims to improve outcomes for patients with squamous cell carcinoma of the head and neck, minimizing the need for extensive prophylactic irradiation.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
rue de l'octroi41260 La Chaussée Saint VictorFrance
Open in maps ↗
Recruiting now
no trials
Conditions studied
1
Partner status
Verified site

More sites in La Chaussée Saint VictorFrance

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Squamous cell carcinoma of head and neck

Not recruiting

Study on the Safety and Tolerance of Durvalumab and Radiotherapy for Patients with Untreated Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou

Squamous cell carcinoma of head and neck

Not recruiting

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.